Phase 3 trial of a small-volume subcutaneous 6-month duration leuprolide acetate treatment for central precocious puberty
Journal of Clinical Endocrinology & Metabolism | Sep 04, 2020
Most read this week
Journal of Clinical Endocrinology & Metabolism | Sep 04, 2020